Menorah-Mivtachim buys into Biolight

Biolight Ltd. said Tuesday that Menorah-Mivtachim Holdings had purchased 5 million shares, or 13 percent, of the company for NIS 20 million.

By MATTHEW KRIEGER
March 7, 2007 07:07

Biolight Ltd. said Tuesday that Menorah-Mivtachim Holdings had purchased 5 million shares, or 13 percent, of the company for NIS 20 million. With the purchase, Menorah-Mivtachim, a securities and insurance firm, became the principal shareholder of Biolight, surpassing Prisma Investment House, which still owns about 10% of the company. Biolight, a life-sciences investment company, has four subsidiaries including Ioptima, which is designing glaucoma treatments using laser-based technology, and Obecure, which is developing drugs to help battle weight control.


Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS

Cookie Settings